Supernus Pharm (SUPN) Posts Q3 Loss of 55c/Share

Supernus Pharm (NASDAQ: SUPN) reported Q3 EPS of ($0.55), $0.07 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
• Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings